연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1937. Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.
Kim KJ, Yang HK, Kim WH, Kang GH
Oncotarget. 2017 Jul 22;8(35):58887-58902. doi: 10.18632/oncotarget.19439. eCollection 2017 Aug 29.
Link
1936. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
Bae JM, Kim JH, Park JH, Park HE, Cho NY, Kang GH
Histopathology. 2018 Feb;72(3):423-432. doi: 10.1111/his.13398. Epub 2017 Dec 4.
Link
1935. Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma.
Jeong S, Lee K, Wen X, Kim Y, Cho NY, Jang JJ, Kang GH
BMC Cancer. 2017 Aug 29;17(1):588. doi: 10.1186/s12885-017-3595-8.
Link
1934. Deletion in HSP110 T17: correlation with wild-type HSP110 expression and prognostic significance in microsatellite-unstable advanced gastric cancers.
Kim KJ, Lee TH, Kim JH, Cho NY, Kim WH, Kang GH.
Hum Pathol. 2017 Sep;67:109-118. doi: 10.1016/j.humpath.2017.08.001. Epub 2017 Aug 12.
Link
1933. Prognostic significance of stromal GREM1 expression in colorectal cancer.
Jang BG, Kim HS, Chang WY, Bae JM, Oh HJ, Wen X, Jeong S, Cho NY, Kim WH, Kang GH.
Hum Pathol. 2017 Apr;62:56-65. doi: 10.1016/j.humpath.2016.12.018. Epub 2016 Dec 30.
Link
1932. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.
Park HE, Kim JH, Cho NY, Lee HS, Kang GH.
Virchows Arch. 2017 Jun 8. doi: 10.1007/s00428-017-2171-6. [Epub ahead of print]
Link
1931. Dominant high expression of wild-type HSP110 defines a poor prognostic subgroup of colorectal carcinomas with microsatellite instability: a whole-section immunohistochemical analysis.
Oh HJ, Kim JH, Lee TH, Park HE, Bae JM, Lee HS, Kang GH
APMIS. 2017 Dec;125(12):1076-1083. doi: 10.1111/apm.12770. Epub 2017 Oct 3.
Link
1930. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer.
Kim YI, Kim YJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kang KW
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1787-1795. doi: 10.1007/s00259-017-3748-7. Epub 2017 Jun 14.
Link
1929. Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma.
Kim YI, Kim YJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kang KW
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1995-2003. doi: 10.1007/s00259-017-3755-8. Epub 2017 Jun 20.
Link
1928. Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors.
Sim SH, Beom SH, Ahn YO, Keam B, Kim TM, Lee SH, Kim DW, Heo DS.
Thorac Cancer. 2016 Mar;7(2):161-6. doi: 10.1111/1759-7714.12304. Epub 2015 Aug 28.
Link